When we think about blood sugar control, we tend to focus on the pancreas and the hormone insulin. But there's another organ that plays an absolutely enormous role in how our bodies handle glucose, and it's one we don't always think of as being involved in metabolic health.

Our muscles.

Skeletal muscle is one of the body's major destinations for glucose after a meal. When insulin is working effectively, muscle cells can take up glucose from the bloodstream and use it for energy or store it for later.

But when those cells become resistant to insulin, that process becomes less efficient, contributing to the elevated blood glucose levels associated with type 2 diabetes.

Now, a new study published in Nature Communications has identified a mitochondrial protein that may help explain part of this process.

And it offers a fascinating insight into why exercise can have such powerful effects on metabolic health.

Why Is Skeletal Muscle So Important for Blood Sugar?

Every time we eat a meal containing carbohydrates, digestion breaks many of those carbohydrates down into sugars, including glucose, which enters the bloodstream.

In response, the pancreas releases insulin.

Insulin acts as a chemical signal, telling certain tissues that glucose is available and helping them take it up from the circulation.

Skeletal muscle is particularly important because it represents such a large proportion of our body mass and accounts for a substantial amount of insulin-stimulated glucose disposal.

Inside muscle cells, insulin activates a series of signalling pathways that encourage specialised glucose transporters, called GLUT4, to move towards the cell membrane.

These transporters allow glucose to enter the muscle cell, where it can be used to produce energy or stored as glycogen.

When muscle becomes insulin resistant, this response is impaired. The body may need to produce more insulin to achieve the same effect, and blood glucose regulation can gradually become more difficult.

This is one reason why maintaining healthy, active muscle tissue is so important for long-term metabolic health.

What Have Scientists Discovered?

The new research focused on a protein called Miro1, which is involved in regulating the behaviour and organisation of mitochondria.

Mitochondria are the specialised structures inside our cells that help convert nutrients into usable energy. They're particularly abundant in muscle tissue because muscle cells have such substantial energy requirements.

But mitochondria aren't simply stationary energy-producing structures. They form dynamic networks that can change their shape, distribution and organisation in response to the needs of the cell.

Miro1 is involved in this process, helping regulate aspects of mitochondrial movement and positioning.

The researchers identified evidence suggesting that the accumulation of Miro1 may be involved in impaired insulin sensitivity within skeletal muscle.

Importantly, their investigation combined observations in people with type 2 diabetes with experimental work designed to explore the underlying biological mechanisms.

In participants with type 2 diabetes, exercise training was associated with a reduction in Miro1 accumulation alongside improvements in insulin sensitivity.

Supporting cellular and animal experiments provided further evidence that Miro1 may influence the processes involved in muscle insulin responsiveness.

This doesn't establish that Miro1 is the single cause of insulin resistance, but it identifies a potentially important piece of a much larger biological puzzle.

What Do Mitochondria Have to Do With Insulin Resistance?

Mitochondria are often described as the powerhouses of our cells, but their influence extends well beyond simply producing energy.

They also participate in metabolic signalling, calcium regulation and the management of cellular stress.

In skeletal muscle, mitochondrial function is closely connected with the way nutrients are processed and how cells respond to changing energy demands.

When these processes become disrupted, they may contribute to an environment in which insulin signalling becomes less effective.

However, the relationship between mitochondrial function and insulin resistance is complicated. Mitochondrial abnormalities may contribute to metabolic dysfunction, but they can also develop as a consequence of other changes associated with obesity, inactivity or type 2 diabetes.

This is why identifying a specific protein such as Miro1 is scientifically interesting.

It gives researchers a more precise molecular pathway to investigate, rather than simply observing that mitochondria behave differently in insulin-resistant muscle.

Why Does Exercise Improve Insulin Sensitivity?

One of the most important messages from this research is something we already have considerable evidence for: physical activity is a powerful way to support glucose regulation.

When muscles contract during exercise, they can increase glucose uptake through mechanisms that don't depend entirely on insulin.

This means that working muscles can draw glucose from the bloodstream even when their usual insulin response is impaired.

Exercise also stimulates a range of longer-term adaptations.

Regular physical activity can increase the muscle's capacity to use glucose, improve insulin signalling, support mitochondrial adaptations and help maintain or increase muscle mass.

Resistance training is particularly valuable because it helps preserve and build the tissue responsible for a substantial proportion of glucose disposal.

Aerobic exercise also provides important benefits, improving cardiovascular fitness and several aspects of metabolic function.

The new findings suggest that changes involving Miro1 could be one additional mechanism contributing to exercise-related improvements in insulin sensitivity.

But that remains an emerging area of research, rather than an established explanation for all the benefits of exercise.

Could Miro1 Become a Treatment Target?

Potentially, but we're a long way from knowing whether that would be useful or safe.

Discovering that a protein participates in a biological process is an important first step. It doesn't automatically mean that blocking or increasing its activity would produce a beneficial treatment.

Miro1 has normal functions within cells, including helping regulate mitochondrial organisation. Interfering with those functions could have consequences beyond insulin signalling.

Researchers would need to establish much more about the protein's role in human muscle, how its activity changes in different metabolic conditions and whether modifying it could improve insulin sensitivity without unwanted effects.

For now, Miro1 is best understood as an interesting research finding, not a clinically validated treatment target.

Your Muscles Are Metabolic Organs, Not Just Something You Exercise

What I find particularly interesting about this study is how it reinforces the importance of looking at skeletal muscle as a metabolic organ.

We often think about muscle in terms of strength, appearance or physical performance.

But muscle is also deeply involved in regulating blood glucose, responding to insulin and managing the nutrients circulating through our bodies.

That has important implications for how we approach metabolic health.

Regular physical activity, particularly a combination of resistance exercise and aerobic movement, is one of the most effective established strategies for improving insulin sensitivity.

And while researchers continue investigating proteins such as Miro1, we don't need to wait for a new molecular treatment to benefit from what we already know.

Maintaining muscle mass, staying physically active and supporting these habits with an appropriate dietary pattern can make a meaningful contribution to metabolic health.

Because looking after our muscles isn't just about staying strong. It's about helping our bodies manage energy and blood glucose more effectively throughout life.

References

Heintz, E.C. et al. (2026) ‘Research investigating Miro1 and skeletal-muscle insulin sensitivity’, Nature Communications. https://doi.org/10.1038/s41467-026-77278-6